Aquestive Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Aquestive Therapeutics, Inc. (AQST) reported Adjustments to Additional Paid in Capital, Warrant Issued of $663.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-11
- Aquestive Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-06-30 was $663.00K.
- Aquestive Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-06-30 was $5.87M.
- Aquestive Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $6.80M.
- Aquestive Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $735.00K, a 89.19% decline from fiscal 2019.
- Aquestive Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $6.80M, a 5762.07% increase from fiscal 2018.
- Aquestive Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $116.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2026-06-30 | $663.00K 10-Q · filed 2026-08-11 | |
| 2022-06-30 | $5.87M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $735.00K 10-K · filed 2021-03-09 | |
| 2019-12-31 | $6.80M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $6.80M 10-Q · filed 2020-11-04 | |
| 2018-12-31 | $116.00K 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |